Ovid Therapeutics Inc. Common Stock (OVID) is a publicly traded Healthcare sector company. As of July 8, 2026, OVID trades at $2.77 with a market cap of $487.13M and a P/E ratio of 0.00. OVID moved +0.36% today. Year to date, OVID is +69.33%; over the trailing twelve months it is +637.97%. Its 52-week range spans $0.24 to $3.11. Analyst consensus is strong buy with an average price target of $5.60. Rallies surfaces OVID's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ovid Therapeutics Inc. Common Stock (OVID) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. OVID moved +0.36% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $2.77 |
| Market Cap | $487.13M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.11 |
| 52-Week Low | $0.24 |
| Volume | 2.59K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.12M |
| Net Income | $-24.17M |
| Gross Margin | 0.00% |
7 analysts cover OVID: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.60.